Stories

As a referral specialist who works at a client site, Alonda Snelling-Faulk enjoys being part of the connection between patients and their test results. And as part of her job, she’s eager to learn all she can about the tests and what they mean for the people Mayo Clinic Laboratories serves.

This week's research roundup features: Therapeutic trials in adult FSGS: lessons learned and the road forward.

Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.

Topic's Include: COVID-19 Queries: Can I develop a COVID infection from the vaccine? Mayo Clinic Q&A podcast: Breaking down COVID-19 vaccine booster approvals, and day of thanks for Mayo Clinic staff Nov. 26.

This week's research roundup features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial.

Topic's Include: COVID-19 Media Only News Briefing: Pfizer low-dose vaccine for kids, Mayo Clinic leads biorepository core for new nationwide research on long-term symptoms of COVID-19, and Mayo Clinic will begin offering booster vaccines.

This week's research roundup features: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study.

Topic's Include: COVID-19 media only news briefing: managing influenza during a pandemic, Mayo Clinic Q and A: COVID-19 vaccine boosters and third doses, and COVID Queries: Delta breakthrough infections.

Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.

As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.

This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.

Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.